13F filer · CIK 1858198
KVP Capital Advisors, LP
SAN FRANCISCO, CA · filing since Q4 2025 · last filing Aug 13, 2026
Reported value
$136.2M
+$2.3M vs prior
Positions
35
New / sold out
6 / 3
Added / reduced
2 / 2
Turnover
13.9%
buys $18.7M · sells $38.0M
Top-10 weight
57.4%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | TANDEM DIABETES CARE INC | +301,000 | – | +$4.5M |
| New | ARRIVENT BIOPHARMA INC | +102,000 | – | +$3.5M |
| New | DESIGN THERAPEUTICS INC | +185,000 | – | +$2.7M |
| New | MINERALYS THERAPEUTICS INC | +84,168 | – | +$2.3M |
| Added | ERASCA INC | +115,000 | +33.8% | +$2.1M |
| New | ARTIVA BIOTHERAPEUTICS INC | +200,000 | – | +$1.9M |
| New | EVOLUS INC | +150,000 | – | +$1.0M |
| Added | COMPASS THERAPEUTICS INC | +271,000 | +54.2% | +$593.5K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | TERNS PHARMACEUTICALS INC | -440,000 | -100.0% | $-23.2M |
| Reduced | AXSOME THERAPEUTICS INC. | -24,200 | -66.9% | $-5.9M |
| Sold out | REVOLUTION MEDICINES INC | -40,200 | -100.0% | $-3.9M |
| Reduced | TRAVERE THERAPEUTICS INC | -52,000 | -57.1% | $-3.0M |
| Sold out | SOLENO THERAPEUTICS INC | -59,700 | -100.0% | $-2.0M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES ICOM NEW | 42,900 | $14.4M | 10.54% |
| 2 | WHITEHAWK THERAPEUTICS INCCOM | 2,165,997 | $9.9M | 7.28% |
| 3 | ERASCA INCCOM | 455,000 | $8.3M | 6.12% |
| 4 | TREVI THERAPEUTICS INCCOM | 414,000 | $7.7M | 5.67% |
| 5 | SUTRO BIOPHARMA INCCOM SHS | 226,575 | $7.5M | 5.52% |
| 6 | TANGO THERAPEUTICS INCCOM | 230,264 | $7.2M | 5.28% |
| 7 | MBX BIOSCIENCES INCCOM | 121,524 | $6.7M | 4.92% |
| 8 | PROTAGONIST THERAPEUTICS INCCOM | 53,000 | $6.5M | 4.77% |
| 9 | EDGEWISE THERAPEUTICS INCCOM | 133,000 | $5.4M | 3.97% |
| 10 | TANDEM DIABETES CARE INCCOM NEW | 301,000 | $4.5M | 3.33% |
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.